Clonidine reduces elevated cerebrospinal fluid catecholamine levels in patients with essential hypertension
- 1 September 1984
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 35 (13) , 1365-1371
- https://doi.org/10.1016/0024-3205(84)90393-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Comparative analysis of indices of central dopaminergic functions in manLife Sciences, 1983
- Cerebrospinal fluid and plasma dopamine-beta-hydroxylase activity in human hypertension.Hypertension, 1981
- Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.Hypertension, 1979
- Exocytosis plays an important role in catecholamine secretion from human pheochromocytomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenololEuropean Journal of Clinical Pharmacology, 1977
- Clinical pharmacology and pharmacokinetics of clonidineClinical Pharmacology & Therapeutics, 1976
- The importance of central adrenergic neurones in renal hypertension in rabbitsThe Journal of Physiology, 1974
- NOREPINEPHRINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM OF MAN: STUDIES USING 3‐METHOXY‐4‐HYDROXYPHENYLETHYLENE GLYCOL LEVELS IN CEREBROSPINAL FLUIDJournal of Neurochemistry, 1973
- Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit: A STUDY WITH INTRACISTERNALLY ADMINISTERED 6-HYDROXYDOPAMINECirculation Research, 1972
- Central adrenergic neurones and the initiation and development of experimental hypertensionCellular and Molecular Life Sciences, 1972